Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.41 |
| ▸ | SLC16A3 | O15427 | 3/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RARB | P10826 | 3/20 | 0.36 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.35 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22784131 | 0.99 | MAPT (0.45) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL29761910 | 0.99 | MAPT (0.45) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL9909995 | 0.89 | PSEN1 (0.35) | MAPTPTGESAPPRARBPLA2G4B | |
| SCHEMBL16982621 | 0.84 | MAPT (0.48) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL16982633 | 0.84 | MAPT (0.48) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL9910005 | 0.84 | PSEN1 (0.37) | APPRARBPSEN1PSEN2APH1B | |
| SCHEMBL14769757 | 0.82 | MAPT (0.68) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL29444967 | 0.82 | PTGES (0.40) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL31713031 | 0.81 | MAPT (0.67) | MAPTPTGESAPPSLC16A3SLC16A1 | |
| SCHEMBL14646292 | 0.81 | PTGES (0.45) | MAPTPTGESAPPSLC16A3SLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586764-B2 | Organic dyes and preparation method thereof and dye-sensitized solar cells | China National Academy of Nanotechnology and Engineering (CN) | 2013-11-19 | — | — | US | disclosed |
| US-20120138133-A1 | ORGANIC DYES AND PREPARATION METHOD THEREOF AND DYE-SENSITIZED SOLAR CELLS | China National Academy of Nanotechnology and Engineering (CN) | 2012-06-07 | — | — | US | disclosed |
| US-20120138133-A1 | ORGANIC DYES AND PREPARATION METHOD THEREOF AND DYE-SENSITIZED SOLAR CELLS | China National Academy of Nanotechnology and Engineering (CN) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120138133-A1 | ORGANIC DYES AND PREPARATION METHOD THEREOF AND DYE-SENSITIZED SOLAR CELLS | UROD, TYR, DDT | MAPT 1437/4885PTGES 4004/4885APP 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.